Children and young adults with acute lymphoblastic leukemia (ALL) and adults with diffuse large B-cell lymphoma (BCGLD) who have not responded to standard treatments will be able to take advantage of CAR T-Cell Therapy. Two facilities offer this treatment: the Sainte-Justine University Hospital Center (CHU Sainte-Justine), for children, and the Maisonneuve-Rosemont Hospital (HMR) of the CIUSSS East-Island-Montreal, for adults.
CAR T-Cell Therapy consists of collecting cells (T lymphocytes) from the patient and transmitting them to a lab operated by a manufacturer in the United States. They are then genetically modified and multiplied for subsequent re-administration to the patient through an IV. The patient's modified cells can then recognize and destroy the cancer cells.
Read more about CAR T (note- this advisory is not available in English) and watch our webcast about CAR T.